NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 115 filers reported holding NURIX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,622 | -21.3% | 14,074 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $140,599 | +12.5% | 14,074 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $124,977 | -19.1% | 14,074 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $154,533 | -15.6% | 14,074 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $183,000 | +34.6% | 14,074 | +31.3% | 0.00% | +33.3% |
| Q2 2022 | $136,000 | -9.3% | 10,717 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $150,000 | -47.6% | 10,717 | +8.7% | 0.00% | -40.0% |
| Q4 2021 | $286,000 | +43.0% | 9,862 | +47.6% | 0.01% | +25.0% |
| Q3 2021 | $200,000 | – | 6,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |